Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

November 14, 2017

Ministers from the eleven countries assessing the Trans-Pacific Partnership (TPP) trade deal have suspended many of the damaging provisions that would have restricted access to medicines and vaccines, a victory for millions of people who rely on affordable medicines worldwide.

September 14, 2017

After 14 years in Kurram district, in the Federally Administered Tribal Areas (FATA), Pakistan, Doctors Without Borders/Médecins Sans Frontières (MSF) is withdrawing from the area. Without providing any explanation, authorities have refused to issue a No Objection Certificate (NOC). With no valid NOC, MSF cannot continue medical activities in Kurram Agency.

July 25, 2017

Greater global attention is needed to prevent and treat AIDS, as too many patients are dying despite the availability of antiretroviral treatment.

May 12, 2016

The World Health Organization has just recommended that countries move toward shorter treatment regimens for some people with drug-resistant tuberculosis (DR-TB), including people co-infected with HIV, children, and people with simple MDR-TB who have not been treated before or and have no known resistance to any of the drugs in the regimen. This recommendation comes following results from a number of large observation cohort studies using the shortened regimen.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

November 30, 2015

JOHANNESBURG/HARARE—The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today warned that lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most often despite sufficient stocks already being present in countries, and called for urgent improvements in ARV supply chains in the region.

March 06, 2014

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

May 09, 2013

MSF teams have treated more than 110 people for blast injuries from election-related violence over the past four days.

February 01, 2013

MSF treated 55 wounded patients in Hangu following the February 1 bombing in the town's market.

December 19, 2012

Regardless of the parties or individuals responsible for the recent escalation of attacks against health workers in Pakistan, both patients and medical workers risk losing their lives while seeking or providing health care

Pages